{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:33:10Z","timestamp":1793291590601,"version":"4.5.0"},"reference-count":280,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015084","name":"Lung Foundation Netherlands","doi-asserted-by":"publisher","award":["NAF10.060"],"award-info":[{"award-number":["NAF10.060"]}],"id":[{"id":"10.13039\/501100015084","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.pharmthera.2022.108115","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T13:14:55Z","timestamp":1642598095000},"page":"108115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Allergen immunotherapy for allergic airway diseases: Use lessons from the past to design a brighter future"],"prefix":"10.1016","volume":"237","author":[{"given":"Laura","family":"Hesse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.N.G.","family":"Oude Elberink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoon J.M.","family":"van Oosterhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn C.","family":"Nawijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb0005","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jaci.2004.01.756","article-title":"Incorrect allergy injections: Allergists\u2019 experiences and recommendations for prevention","volume":"113","author":"Aaronson","year":"2004","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"25","key":"10.1016\/j.pharmthera.2022.108115_bb0010","doi-asserted-by":"crossref","first-page":"17406","DOI":"10.1074\/jbc.R113.546218","article-title":"Eosinophil granule proteins: Form and function","volume":"289","author":"Acharya","year":"2014","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.smim.2003.12.008","article-title":"Pharmacological induction of tolerogenic dendritic cells and regulatory T cells","volume":"16","author":"Adorini","year":"2004","journal-title":"Seminars in Immunology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108115_bb0020","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/all.13749","article-title":"EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma. Allergy: European","volume":"74","author":"Agache","year":"2019","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb0025","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/cea.12102","article-title":"Vitamin D supplementation reduces airway hyperresponsiveness and allergic airway inflammation in a murine model","volume":"43","author":"Agrawal","year":"2013","journal-title":"Clinical and Experimental Allergy"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108115_bb0030","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/90667","article-title":"Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen","volume":"2","author":"Akbari","year":"2001","journal-title":"Nature Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jaci.2010.11.030","article-title":"Mechanisms of allergen-specific immunotherapy","volume":"127","author":"Akdis","year":"2011","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0040","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1172\/JCI2250","article-title":"Role of interleukin 10 in specific immunotherapy","volume":"102","author":"Akdis","year":"1998","journal-title":"The Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0045","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaci.2013.12.1088","article-title":"Mechanisms of allergen-specific immunotherapy: Multiple suppressor factors at work in immune tolerance to allergens","volume":"133","author":"Akdis","year":"2014","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108115_bb0050","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.20032058","article-title":"Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells","volume":"199","author":"Akdis","year":"2004","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0055","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0091-6749(93)90211-W","article-title":"Local nasal immunotherapy for Dermatophagoides-induced rhinitis: Efficacy of a powder extract","volume":"91","author":"Andri","year":"1993","journal-title":"Journal of Allergy and Clinical ImmunologyClinical Immunology"},{"issue":"12","key":"10.1016\/j.pharmthera.2022.108115_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11882-018-0827-1","article-title":"Virus-Like Particles as Carrier Systems to Enhance Immunomodulation in Allergen Immunotherapy","volume":"18","author":"Anzaghe","year":"2018","journal-title":"Current Allergy and Asthma Reports"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108115_bb0065","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1365-2222.2009.03264.x","article-title":"Engineering of major house dust mite allergens der p 1 and der p 2 for allergen-specific immunotherapy","volume":"39","author":"Asturias","year":"2009","journal-title":"Clinical and Experimental Allergy"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108115_bb0070","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/cea.12963","article-title":"Increased prevalence of allergic asthma from 1996 to 2006 and further to 2016\u2014results from three population surveys","volume":"47","author":"Backman","year":"2017","journal-title":"Clinical and Experimental Allergy"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb0075","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/all.12278","article-title":"Vitamin D as an adjunct to subcutaneous allergen immunotherapy in asthmatic children sensitized to house dust mite","volume":"69","author":"Baris","year":"2014","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108115_bb0080","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1084\/jem.20011629","article-title":"In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines","volume":"195","author":"Barrat","year":"2002","journal-title":"Journal of Experimental Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0085","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.4049\/jimmunol.1102832","article-title":"IL-33\u2013Responsive Lineage \u2212 CD25 + CD44 hi Lymphoid Cells Mediate Innate Type 2 Immunity and Allergic Inflammation in the Lungs","volume":"188","author":"Bartemes","year":"2012","journal-title":"The Journal of Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1183\/09031936.00138707","article-title":"Global strategy for asthma management and prevention: GINA executive summary","volume":"31","author":"Bateman","year":"2008","journal-title":"European Respiratory Journal"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108115_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001748","article-title":"Developmental profiles of eczema, wheeze, and rhinitis: Two population-based birth cohort studies","volume":"11","author":"Belgrave","year":"2014","journal-title":"PLoS Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0100","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/all.14036","article-title":"Alum impairs tolerogenic properties induced by allergoid-mannan conjugates inhibiting mTOR and metabolic reprogramming in human DCs","volume":"75","author":"Benito-Villalvilla","year":"2020","journal-title":"Allergy: European Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb0105","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1710-1492-1-2-81","article-title":"Relationship between asthma and rhinitis: Epidemiologic, pathophysiologic, and therapeutic aspects","volume":"1","author":"Bergeron","year":"2005","journal-title":"Allergy, Asthma & Clinical Immunology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb0110","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jaci.2004.02.006","article-title":"Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001","volume":"113","author":"Bernstein","year":"2004","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1081-1206(10)62659-2","article-title":"Clinical efficacy and tolerability of a steady dosage schedule of local nasal immunotherapy. Results of preseasonal treatment in grass pollen rhinitis","volume":"82","author":"Bertoni","year":"1999","journal-title":"Annals of Allergy, Asthma & Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0120","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/all.13635","article-title":"IgG4 drives M2a macrophages to a regulatory M2b-like phenotype: potential implication in immune tolerance","volume":"74","author":"Bianchini","year":"2019","journal-title":"Allergy: European Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0125","first-page":"91","article-title":"Oral immunotherapy in asthma: Is it effective?","volume":"17","author":"Bjorksten","year":"1987","journal-title":"Clinical Allergy"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0130","series-title":"Experimental Researchers on the causes and nature of catarrhus Aestivus (hay-fever and hay-asthma)","author":"Blackely","year":"1873"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0135","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.coi.2015.08.002","article-title":"Genetics of allergy and allergic sensitization: common variants, rare mutations","volume":"36","author":"B\u00f8nnelykke","year":"2016","journal-title":"Current Opinion in Immunology"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108115_bb0140","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.4049\/jimmunol.167.9.4974","article-title":"1\u03b1,25-dihydroxyvitamin D3 has a direct effect on naive CD4 + T cells to enhance the development of Th2 cells","volume":"167","author":"Boonstra","year":"2001","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0145","series-title":"Handbook of experimental pharmacology","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/164_2017_18","article-title":"Histamine release from mast cells and basophils","volume":"Vol. 241","author":"Borriello","year":"2017"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0150","first-page":"894","article-title":"Case of a periodical affection of the eyes and chest","volume":"18","author":"Bostock","year":"1960","journal-title":"Annals of Allergy"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108115_bb0155","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1046\/j.1365-2222.2002.01470.x","article-title":"Total and allergen-specific immunoglobulin a levels in saliva in relation to the development of allergy in infants up to 2 years of age","volume":"32","author":"B\u00f6ttcher","year":"2002","journal-title":"Clinical and Experimental Allergy"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0160","first-page":"1","article-title":"Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma","volume":"9","author":"Bousquet","year":"2019","journal-title":"Clinical and Translational Allergy"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108115_bb0165","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0091-6749(98)70271-4","article-title":"Allergen immunotherapy: Therapeutic vaccines for allergic diseases - A WHO position paper","volume":"102","author":"Bousquet","year":"1998","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb0170","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaci.2006.02.039","article-title":"The role of the mast cell in the pathophysiology of asthma","volume":"117","author":"Bradding","year":"2006","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2010.06.047","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision","author":"Broek","year":"2010","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0180","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2006.01312.x","article-title":"Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce","volume":"62","author":"Canonica","year":"2007","journal-title":"Allergy: European Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0185","doi-asserted-by":"crossref","DOI":"10.1186\/1939-4551-7-6","article-title":"Sublingual immunotherapy: World Allergy Organization position paper 2013 update","author":"Canonica","year":"2014","journal-title":"World Allergy Organization Journal"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108115_bb0190","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.3390\/nu7043011","article-title":"Vitamin D and 1,25(OH)2D regulation of T cells","volume":"7","author":"Cantorna","year":"2015","journal-title":"Nutrients"},{"issue":"October 2017","key":"10.1016\/j.pharmthera.2022.108115_bb0195","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cytogfr.2017.11.004","article-title":"Orchestration of epithelial-derived cytokines and innate immune cells in allergic airway inflammation","volume":"39","author":"Castillo","year":"2018","journal-title":"Cytokine and Growth Factor Reviews"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0200","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1080\/09540105.2020.1799947","article-title":"ISAC multiplex testing\u2013results of examination in 100 patients suffering from atopic dermatitis","volume":"31","author":"\u010celakovsk\u00e1","year":"2020","journal-title":"Food and Agricultural Immunology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108115_bb0205","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/09540105.2015.1007447","article-title":"Food allergy, asthma bronchiale, and rhinitis in atopic dermatitis patients with total immunoglobulin E under and above 200 IU\/ml","volume":"26","author":"\u010celakovsk\u00e1","year":"2015","journal-title":"Food and Agricultural Immunology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2012.05.035","article-title":"Hypoallergenic der p 1\/Der p 2 combination vaccines for immunotherapy of house dust mite allergy","volume":"130","author":"Chen","year":"2012","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0215","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.4049\/jimmunol.179.3.1634","article-title":"Modulatory effects of 1,25-dihydroxyvitamin D 3 on human B cell differentiation","volume":"179","author":"Chen","year":"2007","journal-title":"The Journal of Immunology"},{"issue":"10187","key":"10.1016\/j.pharmthera.2022.108115_bb0220","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/S0140-6736(19)30420-9","article-title":"Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety","volume":"393","author":"Chu","year":"2019","journal-title":"The Lancet"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0225","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaut.2017.07.007","article-title":"Modulation of inflammatory and immune responses by vitamin D","volume":"85","author":"Colotta","year":"2017","journal-title":"Journal of Autoimmunity"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0230","series-title":"The treatment of hay fever by active immunization","first-page":"108","author":"Cooke","year":"1915"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0235","first-page":"577","article-title":"Hayfever and asthma: The uses and limitations of desensitization","volume":"107","author":"Cooke","year":"1918","journal-title":"NY Med J"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb0240","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1084\/jem.66.6.689","article-title":"Studies on immunity in a type of human allergy (hay fever): serologic response of non-sensitive individuals to pollen injections","volume":"66","author":"Cooke","year":"1937","journal-title":"Journal of Experimental Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108115_bb0245","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/cea.12488","article-title":"Fel d 1-derived synthetic peptide immuno-regulatory epitopes show a long-term treatment effect in cat allergic subjects","volume":"45","author":"Couroux","year":"2015","journal-title":"Clinical and Experimental Allergy"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb0250","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1081-1206(10)60003-8","article-title":"Accelerated immunotherapy schedules: Review of efficacy and safety","volume":"97","author":"Cox","year":"2006","journal-title":"Annals of Allergy, Asthma & Immunology"},{"issue":"1 SUPPL","key":"10.1016\/j.pharmthera.2022.108115_bb0255","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","article-title":"Allergen immunotherapy: A practice parameter third update","volume":"127","author":"Cox","year":"2011","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0260","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/0091-6749(91)90395-5","article-title":"Local immunotherapy with dermatophagoides extract in asthma","volume":"87","author":"Crimi","year":"1991","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108115_bb0265","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1398-9995.1986.tb00309.x","article-title":"Terbutaline slow-release tablets in children with asthma","volume":"41","author":"Croner","year":"1986","journal-title":"Allergy"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0270","first-page":"16","article-title":"The immunizing cure of hay fever","volume":"77","author":"Curtis","year":"1900","journal-title":"Medical Newsletter"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0275","first-page":"1","article-title":"Climate change, allergy and asthma, and the role of tropical forests","volume":"10","author":"D\u2019Amato","year":"2017","journal-title":"World Allergy Organization Journal"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0280","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/02770903.2018.1455858","article-title":"Burden of asthma among patients adherent to ICS\/LABA: A real-world study","volume":"56","author":"Davis","year":"2019","journal-title":"Journal of Asthma"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108115_bb0285","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1111\/j.1398-9995.2009.02196.x","article-title":"House dust mite control measures for asthma","volume":"64","author":"De Blay","year":"2009","journal-title":"Allergy: European Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0290","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1084\/jem.20040035","article-title":"Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen","volume":"200","author":"De Heer","year":"2004","journal-title":"Journal of Experimental Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0295","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/imr.12542","article-title":"Interplay between barrier epithelial cells and dendritic cells in allergic sensitization through the lung and the skin","volume":"278","author":"Deckers","year":"2017","journal-title":"Immunological Reviews"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb0300","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/all.13072","article-title":"Allergy in severe asthma","volume":"72","author":"Del Giacco","year":"2017","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0305","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41588-017-0014-7","article-title":"Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks","volume":"50","author":"Demenais","year":"2018","journal-title":"Nature Genetics"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108115_bb0310","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0091-6749(97)70069-1","article-title":"Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children","volume":"99","author":"Des Roches","year":"1997","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"JUN","key":"10.1016\/j.pharmthera.2022.108115_bb0315","first-page":"1","article-title":"Epidemiology of asthma in children and adults","volume":"7","author":"Dharmage","year":"2019","journal-title":"Frontiers in Pediatrics"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb0320","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2567.2011.03482.x","article-title":"Vitamin D3: A helpful immuno-modulator","volume":"134","author":"Di Rosa","year":"2011","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb0325","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/WOX.0b013e3182218920","article-title":"Allergen immunotherapy: A centenary celebration","volume":"4","author":"Durham","year":"2011","journal-title":"World Allergy Organization Journal"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108115_bb0330","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM199908123410702","article-title":"Long-term clinical efficacy of grass-pollen immunotherapy","volume":"341","author":"Durham","year":"1999","journal-title":"The New England Journal of Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb0335","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0091-6749(96)70205-1","article-title":"Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for Interferon-\u03b3","volume":"97","author":"Durham","year":"1996","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108115_bb0340","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1365-2222.1997.tb01252.x","article-title":"Immunological changes during specific immunotherapy of grass pollen allergy: Reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen","volume":"27","author":"Ebner","year":"1997","journal-title":"Clinical and Experimental Allergy"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb0345","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1398-9995.1988.tb00921.x","article-title":"In vitro studies of degradation of birch and timothy pollen allergen preparations by human duodenal juice","volume":"43","author":"Einarsson","year":"1988","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0350","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12967-018-1701-6","article-title":"Epicutaneous immunotherapy in rhino-conjunctivitis and food allergies: A review of the literature","volume":"16","author":"Esposito","year":"2018","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0355","series-title":"Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases","first-page":"1","author":"European Medicines Agency","year":"2009"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108115_bb0360","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1084\/jem.20051615","article-title":"Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion","volume":"203","author":"Fallon","year":"2006","journal-title":"Journal of Experimental Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0365","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nri2039","article-title":"Suppression of TH2-type allergic reactions by helminth infection","volume":"7","author":"Fallon","year":"2007","journal-title":"Nature Reviews Immunology"},{"issue":"23","key":"10.1016\/j.pharmthera.2022.108115_bb0370","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.4103\/0366-6999.194642","article-title":"Suppression of immunotherapy on group 2 Innate lymphoid cells in allergic rhinitis","volume":"129","author":"Fan","year":"2016","journal-title":"Chinese Medical Journal"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0149180","article-title":"Vitamin D supplementation reduces induction of epithelial-mesenchymal transition in allergen sensitized and challenged mice","volume":"11","author":"Fischer","year":"2016","journal-title":"PLoS One"},{"issue":"6821","key":"10.1016\/j.pharmthera.2022.108115_bb0380","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0140-6736(54)91620-7","article-title":"Prophylaxis of summer hay-fever and asthma","volume":"263","author":"Frankland","year":"1954","journal-title":"The Lancet"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108115_bb0385","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1517\/14712590903146869","article-title":"Development of an allergen extract for sublingual immunotherapy - evaluation of staloral","volume":"9","author":"Frati","year":"2009","journal-title":"Expert Opinion on Biological Therapy"},{"issue":"4594","key":"10.1016\/j.pharmthera.2022.108115_bb0390","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0140-6736(01)40417-X","article-title":"Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine","volume":"178","author":"Freeman","year":"1911","journal-title":"The Lancet"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb0395","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrd3838","article-title":"Targeting eosinophils in allergy, inflammation and beyond","volume":"12","author":"Fulkerson","year":"2013","journal-title":"Nature Reviews Drug Discovery"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108115_bb0400","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.autrev.2019.02.006","article-title":"Immune checkpoints and the regulation of tolerogenicity in dendritic cells: Implications for autoimmunity and immunotherapy","volume":"18","author":"Funes","year":"2019","journal-title":"Autoimmunity Reviews"},{"issue":"7203","key":"10.1016\/j.pharmthera.2022.108115_bb0405","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature07204","article-title":"The development of allergic inflammation","volume":"454","author":"Galli","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0410","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pharmthera.2016.10.010","article-title":"Mast cell and eosinophil surface receptors as targets for anti-allergic therapy","volume":"170","author":"Gangwar","year":"2017","journal-title":"Pharmacology and Therapeutics"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0415","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jaci.2014.05.049","article-title":"Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation","volume":"134","author":"Georas","year":"2014","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"1 PART 1","key":"10.1016\/j.pharmthera.2022.108115_bb0420","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0091-6749(83)90549-3","article-title":"Local intranasal immunotherapy for grass-allergic rhinitis","volume":"71","author":"Georgitis","year":"1983","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0425","first-page":"46","article-title":"Pocket guide for asthma management and prevention (for adults and children older than 5 years)","author":"GINA 2020","year":"2020","journal-title":"Global Initiative for Asthma"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb0430","first-page":"685","article-title":"Global initiative for asthma: Global strategy for asthma management and prevention, 2020","volume":"36","author":"Global Initiative for Asthma","year":"2020","journal-title":"GINA"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0435","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.anai.2018.06.026","article-title":"Mechanisms of allergen-specific immunotherapy: Diverse mechanisms of immune tolerance to allergens","volume":"121","author":"G\u0142obi\u0144ska","year":"2018","journal-title":"Annals of Allergy, Asthma & Immunology"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108115_bb0440","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.4049\/jimmunol.165.9.4773","article-title":"Cutting edge: TGF-\u03b2 inhibits Th type 2 development through inhibition of GATA-3 expression","volume":"165","author":"Gorelik","year":"2000","journal-title":"The Journal of Immunology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb0445","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2567.2009.03222.x","article-title":"1,25-dihydroxyvitamin D3 enhances the ability of transferred CD4+ CD25+ cells to modulate T helper type 2-driven asthmatic responses","volume":"130","author":"Gorman","year":"2010","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0450","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nri2273","article-title":"IgE in allergy and asthma today","volume":"8","author":"Gould","year":"2008","journal-title":"Nature Reviews Immunology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb0455","doi-asserted-by":"crossref","first-page":"L369","DOI":"10.1152\/ajplung.00456.2018","article-title":"Oxidative stress and macrophages: Driving forces behind exacerbations of asthma and chronic obstructive pulmonary disease?","volume":"316","author":"de Groot","year":"2019","journal-title":"American Journal of Physiology - Lung Cellular and Molecular Physiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2012.11.028","article-title":"Decoding asthma: Translating genetic variation in IL33 and IL1RL1 into disease pathophysiology","volume":"131","author":"Grotenboer","year":"2013","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0465","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.anai.2018.07.014","article-title":"New approaches to allergen immunotherapy","volume":"121","author":"Gunawardana","year":"2018","journal-title":"Annals of Allergy, Asthma & Immunology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108115_bb0470","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0091-6749(99)70077-1","article-title":"Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1","volume":"104","author":"van Hage-Hamsten","year":"1999","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"March","key":"10.1016\/j.pharmthera.2022.108115_bb0475","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijpharm.2019.03.040","article-title":"Evaluation of size and dose effects of rChe a 3 allergen loaded PLGA nanoparticles on modulation of Th2 immune responses by sublingual immunotherapy in mouse model of rhinitis allergic","volume":"563","author":"Hajavi","year":"2019","journal-title":"International Journal of Pharmaceutics"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2013.12.003","article-title":"Airway epithelial regulation of pulmonary immune homeostasis and inflammation","volume":"151","author":"Hallstrand","year":"2014","journal-title":"Clinical Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0485","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nri2275","article-title":"Dendritic cells and epithelial cells: Linking innate and adaptive immunity in asthma","volume":"8","author":"Hammad","year":"2008","journal-title":"Nature Reviews Immunology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108115_bb0490","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jaci.2009.07.040","article-title":"Exagerated IL-17 response to epicutaneous sensitization mediates airway inflammation in abscence IL-13 and IL-4","volume":"124","author":"He","year":"2009","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0495","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4049\/jimmunol.1301656","article-title":"25-hydroxvitamin D 3 promotes the long-term effect of specific immunotherapy in a murine allergy model","volume":"193","author":"Heine","year":"2014","journal-title":"The Journal of Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0500","first-page":"40","article-title":"Bronchial hypersensitization and hyposensitization in man","volume":"2","author":"Herxheimer","year":"1951","journal-title":"International Archives of Allergy and Applied Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0505","first-page":"189","article-title":"Further observations on induced asthma and bronchial hyposensitization","volume":"3","author":"Herxheimer","year":"1952","journal-title":"International Archives of Allergy and Applied Immunology"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108115_bb0510","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/all.13135","article-title":"Novel approaches and perspectives in allergen immunotherapy","volume":"72","author":"Hoffmann","year":"2017","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108115_bb0515","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.4049\/jimmunol.171.5.2644","article-title":"Regulation of eosinophilopoiesis in a murine model of asthma","volume":"171","author":"Hogan","year":"2003","journal-title":"The Journal of Immunology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108115_bb0520","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nm.2731","article-title":"Innate and adaptive immune responses in asthma","volume":"18","author":"Holgate","year":"2012","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0525","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/sj.gene.6363723","article-title":"Linkage analysis of the 5q31-33 candidate region for asthma in 240 UK families","volume":"2","author":"Holloway","year":"2001","journal-title":"Genes and Immunity"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb0530","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/0008-8749(87)90045-1","article-title":"Suppression of IgE responses by passive antigen inhalation: Dissociation of local (mucosal) and systemic immunity","volume":"104","author":"Holt","year":"1987","journal-title":"Cellular Immunology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb0535","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/nri2236","article-title":"Regulation of immunological homeostasis in the respiratory tract","volume":"8","author":"Holt","year":"2008","journal-title":"Nature Reviews Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0540","first-page":"303","article-title":"Prick-tests and serological tests in the diagnosis of allergic reactivity to enzymes used in washing products","volume":"28","author":"How","year":"1971","journal-title":"British Journal of Industrial Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0545","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s40629-018-0054-2","article-title":"Vitamin A and D in allergy: From experimental animal models and cellular studies to human disease","volume":"27","author":"Hufnagl","year":"2018","journal-title":"Allergo Journal International"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0550","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaci.2007.05.042","article-title":"Risk of developing asthma in young children with atopic eczema: A systematic review","volume":"120","author":"van der Hulst","year":"2007","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0555","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM197807272990401","article-title":"A controlled trial of immunotherapy in insect hypersensitivity","volume":"299","author":"Hunt","year":"1978","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2012.10.056","article-title":"Intralymphatic allergen-specific immunotherapy: An effective and safe alternative treatment route for pollen-induced allergic rhinitis","author":"Hylander","year":"2013","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11882-015-0586-1","article-title":"Adherence to sublingual immunotherapy","volume":"16","author":"Incorvaia","year":"2016","journal-title":"Current Allergy and Asthma Reports"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108115_bb0570","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaci.2012.06.034","article-title":"IL-13 in asthma and allergic disease: Asthma phenotypes and targeted therapies","volume":"130","author":"Ingram","year":"2012","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0575","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1600-065X.1978.tb01462.x","article-title":"Mechanisms of reaginic hypersensitivity and immunotherapy","volume":"41","author":"Ishizaka","year":"1978","journal-title":"Immunological Reviews"},{"issue":"l","key":"10.1016\/j.pharmthera.2022.108115_bb0580","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0019-2791(64)90043-6","article-title":"Blocking of Prausnitz-kustner sensitization with reagin by \u201cA-chain\u201d of human yla-globulin*","volume":"1","author":"Ishizaka","year":"1964","journal-title":"Immunochemistry"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108115_bb0585","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1398-9995.2007.01451.x","article-title":"Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study","volume":"62","author":"Jacobsen","year":"2007","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0590","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2045-7022-2-8","article-title":"Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy","volume":"2","author":"Jacobsen","year":"2012","journal-title":"Clinical and Translational Allergy"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0595","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/ACI.0000000000000335","article-title":"Allergen immunotherapy: An updated review of safety","volume":"17","author":"James","year":"2017","journal-title":"Current Opinion in Allergy and Clinical Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0600","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11882-016-0600-2","article-title":"Potential mechanisms for IgG4 inhibition of immediate hypersensitivity reactions","volume":"16","author":"James","year":"2016","journal-title":"Current Allergy and Asthma Reports"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108115_bb0605","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.4049\/jimmunol.0803217","article-title":"1,25-dihydroxyvitamin D 3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3","volume":"183","author":"Jeffery","year":"2009","journal-title":"The Journal of Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0610","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40413-015-0060-5","article-title":"Aluminium in allergies and allergen immunotherapy","volume":"8","author":"Jensen-Jarolim","year":"2015","journal-title":"World Allergy Organization Journal"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108115_bb0615","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev.mi.14.100160.002013","article-title":"Immunological speculations","volume":"14","author":"Jerne","year":"1960","journal-title":"Annual Review of Microbiology"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0620","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2500\/aap.2016.37.3921","article-title":"The clinical effect of vitamin D supplementation combined with grassspecific sublingual immunotherapy in children with allergic rhinitis","volume":"37","author":"Jerzynska","year":"2016","journal-title":"Allergy and Asthma Proceedings"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb0625","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/eji.200425599","article-title":"Direct intralymphatic injection of peptide vaccines enhances immunogenicity","volume":"35","author":"Johansen","year":"2005","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0630","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jaci.2003.12.591","article-title":"Revised nomenclature for allergy for global use: report of the nomenclature review committee of the World Allergy Organization, October 2003","volume":"113","author":"Johansson","year":"2004","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0635","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000232376","article-title":"Use of glutaraldehyde-modified timothy grass pollen extract in nasal hyposensitisation treatment of hay fever","volume":"60","author":"Johansson","year":"1979","journal-title":"International Archives of Allergy and Immunology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108115_bb0640","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1542\/peds.42.5.793","article-title":"The value of hyposensitization therapy for bronchial asthma in children--a 14-year study","volume":"42","author":"Johnstone","year":"1968","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108115_bb0645","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S2213-2600(17)30306-5","article-title":"Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data","volume":"5","author":"Jolliffe","year":"2018","journal-title":"The Lancet Respiratory Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108115_bb0650","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.192.9.1213","article-title":"Induction of interleukin 10-producing , nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells","volume":"192","author":"Jonuleit","year":"2000","journal-title":"Journal of Experimental Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb0655","doi-asserted-by":"crossref","first-page":"885","DOI":"10.4168\/aair.2019.11.6.885","article-title":"Effects of serum vitamin D and efficacy of subcutaneous immunotherapy in adult patients with allergic rhinitis","volume":"11","author":"Joudi","year":"2019","journal-title":"Allergy, Asthma & Immunology Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108115_bb0660","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/eji.200322919","article-title":"IL-10 and TGF-\u03b2 cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy","volume":"33","author":"Jutel","year":"2003","journal-title":"European Journal of Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0665","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jaci.2005.06.004","article-title":"Allergen-specific immunotherapy with recombinant grass pollen allergens","volume":"116","author":"Jutel","year":"2005","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108115_bb0670","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.4049\/jimmunol.154.8.4187","article-title":"Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-\u03b3 secretion in specific allergen-stimulated T cell cultures","volume":"154","author":"Jutel","year":"1995","journal-title":"Journal of Immunology"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108115_bb0675","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.4049\/jimmunol.154.8.4187","article-title":"Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-\u03b3 secretion in specific allergen-stimulated T cell cultures","volume":"154","author":"Jutel","year":"1995","journal-title":"Journal of Immunology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108115_bb0680","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s40629-018-0059-x","article-title":"SCIT with a high-dose house dust mite allergoid is well tolerated: safety data from pooled clinical trials and more than 10 years of daily practice analyzed in different subgroups","volume":"27","author":"Klimek","year":"2018","journal-title":"Allergo Journal International"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108115_bb0685","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ni.3489","article-title":"Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis","volume":"17","author":"Klose","year":"2016","journal-title":"Nature Immunology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb0690","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.4049\/jimmunol.181.6.3755","article-title":"Cutting edge: Alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome","volume":"181","author":"Kool","year":"2008","journal-title":"The Journal of Immunology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108115_bb0695","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1084\/jem.20071087","article-title":"Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells","volume":"205","author":"Kool","year":"2008","journal-title":"Journal of Experimental Medicine"},{"issue":"33","key":"10.1016\/j.pharmthera.2022.108115_bb0700","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1016\/j.vaccine.2014.05.063","article-title":"Aluminium in allergen-specific subcutaneous immunotherapy - A German perspective","volume":"32","author":"Kramer","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0705","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/imr.12557","article-title":"Innate and adaptive type 2 immunity in lung allergic inflammation","volume":"278","author":"Kubo","year":"2017","journal-title":"Immunological Reviews"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb0710","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jaci.2006.01.040","article-title":"Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults","volume":"117","author":"Kundig","year":"2006","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108115_bb0715","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/eji.201646319","article-title":"T cell derived IL-10 is dispensable for tolerance induction in a murine model of allergic airway inflammation","volume":"46","author":"Kunz","year":"2016","journal-title":"European Journal of Immunology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108115_bb0720","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1172\/JCI8107","article-title":"Myeloid dendritic cells induce Th2 responses to inhaled antigens, leading to eosinophilic airway inflamation","volume":"106","author":"Lambrecht","year":"2000","journal-title":"Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108115_bb0725","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nm.2737","article-title":"The airway epithelium in asthma","volume":"18","author":"Lambrecht","year":"2012","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0730","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ni.3049","article-title":"The immunology of asthma","volume":"16","author":"Lambrecht","year":"2015","journal-title":"Nature Immunology"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108115_bb0735","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/ni.3829","article-title":"The immunology of the allergy epidemic and the hygiene hypothesis","volume":"18","author":"Lambrecht","year":"2017","journal-title":"Nature Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0740","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.coi.2009.01.004","article-title":"Mechanism of action of clinically approved adjuvants","volume":"21","author":"Lambrecht","year":"2009","journal-title":"Current Opinion in Immunology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108115_bb0745","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.jaci.2014.07.029","article-title":"Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy","volume":"134","author":"Lao-Araya","year":"2014","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0750","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pharmthera.2005.05.004","article-title":"Peptide therapy for allergic diseases: Basic mechanisms and new clinical approaches","volume":"108","author":"Larch\u00e9","year":"2005","journal-title":"Pharmacology and Therapeutics"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108115_bb0755","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nri1934","article-title":"Immunological mechanisms of allergen-specific immunotherapy","volume":"6","author":"Larch\u00e9","year":"2006","journal-title":"Nature Reviews Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0760","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000230343","article-title":"Effect of combinations of inbred strain, antigen, and antigen dose on immune responsiveness and reagin production in the mouse","volume":"39","author":"Levine","year":"1970","journal-title":"International Archives of Allergy and Immunology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb0765","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4049\/jimmunol.97.2.203","article-title":"Studies on the mechanisms of hypersensitivity phenomena. XIV. Passive sensitization in vitro of human leukocytes to ragweed pollen antigen","volume":"97","author":"Levy","year":"1966","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0770","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0140-6736(04)15592-X","article-title":"Relation of CD4+CD25+ regulatory T-cell suppression of allergen- driven T-cell activation to atopic status and expression of allergic disease","volume":"363","author":"Ling","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0775","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000222674","article-title":"Local nasal immunotherapy: Efficacy of dermatophagoides farinae-chitosan vaccine in murine asthma","volume":"150","author":"Liu","year":"2009","journal-title":"International Archives of Allergy and Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0780","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ymeth.2013.10.008","article-title":"Advances in allergen-microarray technology for diagnosis and monitoring of allergy: The MeDALL allergen-chip","volume":"66","author":"Lupinek","year":"2014","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0785","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/cei.12041","article-title":"Cytotoxic T lymphocyte antigen 4-immunoglobulin G is a potent adjuvant for experimental allergen immunotherapy","volume":"172","author":"Maazi","year":"2013","journal-title":"Clinical and Experimental Immunology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108115_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.10.043","article-title":"Parameters determining the efficacy of CD32 to inhibit activation of Fc\u03b5RI in human basophils","volume":"137","author":"MacGlashan","year":"2016","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"778","key":"10.1016\/j.pharmthera.2022.108115_bb0795","first-page":"352","article-title":"Asthma and viral infections","volume":"98","author":"Mackay","year":"1985","journal-title":"New Zealand Medical Journal"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0800","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/mi.2007.6","article-title":"The immune geography of IgA induction and function","volume":"1","author":"MacPherson","year":"2008","journal-title":"Mucosal Immunology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108115_bb0805","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1380-2933(97)10005-7","article-title":"The TH1\/TH2 paradigm in allergy","volume":"3","author":"Maggi","year":"1998","journal-title":"Immunotechnology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb0810","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaip.2014.01.005","article-title":"Allergen immunotherapy: Clinical outcomes assessment","volume":"2","author":"Makatsori","year":"2014","journal-title":"The Journal of Allergy and Clinical Immunology. In Practice"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108115_bb0815","first-page":"705","article-title":"Studies on \u201callergoids\u201d prepared from naturally occurring allergens. I. Assay of allergenicity and antigenicity of formalinized rye group I component","volume":"18","author":"Marsh","year":"1970","journal-title":"Immunology"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0820","article-title":"Vitamin D for the management of asthma","volume":"9","author":"Martineau","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0825","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000210381","article-title":"Intralymphatic injections as a new administration route for allergen-specific immunotherapy","volume":"150","author":"Mart\u00ednez-G\u00f3mez","year":"2009","journal-title":"International Archives of Allergy and Immunology"},{"issue":"93","key":"10.1016\/j.pharmthera.2022.108115_bb0830","article-title":"The biology of eosinophils and their role in asthma","volume":"4","author":"McBrien","year":"2017","journal-title":"Frontiers in Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0835","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2222.1975.tb01863.x","article-title":"Nasal hyposensitization and hay fever","volume":"5","author":"Mehta","year":"1975","journal-title":"Clinical & Experimental Allergy"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0840","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.otc.2011.03.010","article-title":"Pharmacotherapy for allergic rhinitis","volume":"44","author":"Melvin","year":"2011","journal-title":"Otolaryngologic Clinics of North America"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108115_bb0845","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ni.2131","article-title":"Innate lymphoid cells promote lung tissue homeostasis following acute influenza virus infection","volume":"12","author":"Monticelli","year":"2012","journal-title":"Nature Immunology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb0850","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1398-9995.1987.tb00362.x","article-title":"High dose grass pollen tablets used for hyposensitization in hay fever patients: A one-year double blind placebo-controlled study","volume":"42","author":"Mosbech","year":"1987","journal-title":"Allergy"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0855","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annual Review of Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0860","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0167-5699(96)80606-2","article-title":"The expanding universe of T-cell subsets: Th1, Th2 and more","volume":"17","author":"Mosmann","year":"1996","journal-title":"Immunology Today"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108115_bb0865","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00281-016-0565-1","article-title":"IgE and mast cells in host defense against parasites and venoms","volume":"38","author":"Mukai","year":"2016","journal-title":"Seminars in Immunopathology"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0870","first-page":"2014","article-title":"European academy of allergy and clinical immunology congress","volume":"1","author":"Muraro","year":"2014","journal-title":"EAACI"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb0875","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.imbio.2007.03.002","article-title":"Allergies, infections and the hygiene hypothesis - The epidemiological evidence","volume":"212","author":"von Mutius","year":"2007","journal-title":"Immunobiology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108115_bb0880","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1084\/jem.194.5.629","article-title":"Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor \u03b2","volume":"194","author":"Nakamura","year":"2001","journal-title":"Journal of Experimental Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb0885","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.4049\/jimmunol.113.6.1716","article-title":"Specific suppression of delayed hypersensitivity: the possible presence of a suppressor B cell in the regulation of delayed hypersensitivity","volume":"113","author":"Neta","year":"1974","journal-title":"Journal of Immunology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb0890","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.4049\/jimmunol.113.6.1716","article-title":"Specific suppression of delayed hypersensitivity: the possible presence of a suppressor B cell in the regulation of delayed hypersensitivity","volume":"113","author":"Neta","year":"1974","journal-title":"Journal of Immunology"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108115_bb0895","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1128\/AAC.49.10.3991-3996.2005","article-title":"From the Th1\/Th2 Paradigm towards a Toll-Like Receptor\/ T helper bias","volume":"49","author":"Netea","year":"2005","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2022.108115_bb0900","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1073\/pnas.0404735101","article-title":"Vaccination with genetically engineered allergens prevents progression of allergic disease","volume":"101","author":"Niederberger","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb0905","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jaci.2017.09.052","article-title":"Safety and efficacy of immunotherapy with the recombinant B- cell epitope\u2013based grass pollen vaccine BM32","volume":"142","author":"Niederberger","year":"2018","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0910","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jaci.2016.06.044","article-title":"Efficacy of house dust mite SLIT-Tablet in North American adolescents and adults in a randomized, placebo-controlled trial","author":"Nolte","year":"2016","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"4580","key":"10.1016\/j.pharmthera.2022.108115_bb0915","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/S0140-6736(00)78276-6","article-title":"Prophylactic inoculation against hay fever","volume":"177","author":"Noon","year":"1911","journal-title":"The Lancet"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb0920","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1164\/ajrccm.154.6.8970345","article-title":"Treatment of cat allergy with T-cell reactive peptides","volume":"154","author":"Norman","year":"1996","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108115_bb0925","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jaci.2012.04.039","article-title":"Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2","volume":"130","author":"Novak","year":"2012","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0930","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-065X.2011.01029.x","article-title":"The genetics of asthma and allergic disease: A 21st Century perspective","volume":"242","author":"Ober","year":"2011","journal-title":"Immunological Reviews"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0935","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-2222.1997.tb00671.x","article-title":"House dust mite immunotherapy results in a decrease in Der p 2-specific IFN-\u03b3 and IL-4 expression by circulating T lymphocytes","volume":"27","author":"O\u2019Brien","year":"1997","journal-title":"Clinical and Experimental Allergy"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb0940","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/all.12996","article-title":"House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis","volume":"72","author":"Okamoto","year":"2017","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0945","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0091-6749(94)90233-X","article-title":"Safety and efficacy of oral immunotherapy with standardized cat extract","volume":"93","author":"Oppenheimer","year":"1994","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0950","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/imr.12555","article-title":"Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells","volume":"278","author":"Palomares","year":"2017","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0955","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(97)07055-4","article-title":"Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis","volume":"351","author":"Passalacqua","year":"1998","journal-title":"Lancet"},{"issue":"Suppl. 33","key":"10.1016\/j.pharmthera.2022.108115_bb0960","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1398-9995.1997.tb04798.x","article-title":"Local nasal immunotherapy: Experimental evidences and general considerations","volume":"52","author":"Passalacqua","year":"1997","journal-title":"Allergy"},{"key":"10.1016\/j.pharmthera.2022.108115_bb0965","first-page":"1","article-title":"30 years of sublingual immunotherapy","volume":"00","author":"Passalacqua","year":"2019","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0970","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.iac.2015.08.001","article-title":"Allergen immunotherapy: history and future developments","volume":"36","author":"Passalacqua","year":"2016","journal-title":"Immunology and Allergy Clinics of North America"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2012.07.028","article-title":"Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: A randomized, placebo-controlled study","volume":"131","author":"Patel","year":"2013","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108115_bb0980","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1046\/j.1365-2222.2000.00869.x","article-title":"Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wild-type by skin prick and intradermal testing: Results obtained in a french population","volume":"30","author":"Pauli","year":"2000","journal-title":"Clinical and Experimental Allergy"},{"issue":"22","key":"10.1016\/j.pharmthera.2022.108115_bb0985","first-page":"1394","article-title":"Allergenic group specificity & therapeutic consequences in asthma; specific desensitization method by epicutaneous route","volume":"33","author":"Pautrizel","year":"1957","journal-title":"La Semaine des H\u00f4pitaux"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb0990","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4049\/jimmunol.178.1.145","article-title":"1,25-dihydroxyvitamin D 3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells","volume":"178","author":"Penna","year":"2007","journal-title":"The Journal of Immunology"},{"issue":"6442","key":"10.1016\/j.pharmthera.2022.108115_bb0995","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw4295","article-title":"Protein crystallization promotes type 2 immunity and is reversible by antibody treatment","volume":"364","author":"Persson","year":"2019","journal-title":"Science (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb1000","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12948-016-0044-1","article-title":"Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB\/c mice","volume":"14","author":"Petrarca","year":"2016","journal-title":"Clinical and Molecular Allergy"},{"issue":"S108","key":"10.1016\/j.pharmthera.2022.108115_bb1005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/all.14077","article-title":"Perspectives in allergen immunotherapy: 2019 and beyond","volume":"74","author":"Pfaar","year":"2019","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108115_bb1010","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.chest.2017.09.005","article-title":"Vitamin D in asthma: Mechanisms of action and considerations for clinical trials","volume":"153","author":"Pfeffer","year":"2018","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb1015","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/jama.1926.02670290022008","article-title":"Relief of hay-fever by intradermal injections of pollen extract","volume":"86","author":"Phillips","year":"1926","journal-title":"JAM"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb1020","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/cei.12367","article-title":"Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-\u03b1 agents","volume":"177","author":"Picchianti Diamanti","year":"2014","journal-title":"Clinical and Experimental Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb1025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000342422","article-title":"The value of identifying major T cell epitopes of clinically important allergens","volume":"160","author":"Pickl","year":"2012","journal-title":"International Archives of Allergy and Immunology"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108115_bb1030","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.4049\/jimmunol.178.7.4658","article-title":"Grass pollen immunotherapy induces an allergen-specific IgA2 antibody response associated with mucosal TGF-\u03b2 expression","volume":"178","author":"Pilette","year":"2007","journal-title":"The Journal of Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb1035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000260078","article-title":"Relevant B cell epitopes in allergic disease","volume":"152","author":"Pom\u00e9s","year":"2010","journal-title":"International Archives of Allergy and Immunology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb1040","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/thoraxjnl-2011-200606","article-title":"The composition of house dust mite is critical for mucosal barrier dysfunction and allergic sensitisation","volume":"67","author":"Post","year":"2012","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb1045","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/cea.12554","article-title":"Immunoregulatory T cell epitope peptides: The new frontier in allergy therapy","volume":"45","author":"Prickett","year":"2015","journal-title":"Clinical and Experimental Allergy"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108115_bb1050","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/j.1365-2222.2008.03042.x","article-title":"Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives","volume":"38","author":"Purohit","year":"2008","journal-title":"Clinical and Experimental Allergy"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb1055","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.jaci.2008.03.013","article-title":"Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa","volume":"121","author":"Radulovic","year":"2008","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"3 PART 1","key":"10.1016\/j.pharmthera.2022.108115_bb1060","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0091-6749(88)90021-8","article-title":"The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients","volume":"82","author":"Rak","year":"1988","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2022.108115_bb1065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2006.04.064","article-title":"Long-term follow-up of atopic dermatitis: Retrospective analysis of related risk factors and association with concomitant allergic diseases","author":"Ricci","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108115_bb1070","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/cea.13254","article-title":"Birch pollen-specific subcutaneous immunotherapy reduces ILC2 frequency but does not suppress IL-33 in mice","volume":"48","author":"van Rijt","year":"2018","journal-title":"Clinical and Experimental Allergy"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb1075","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1398-9995.2010.02541.x","article-title":"100 years of hyposensitization: History of allergen-specific immunotherapy (ASIT)","volume":"66","author":"Ring","year":"2011","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb1080","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jaci.2016.06.003","article-title":"Regulatory T cells in allergic diseases","volume":"138","author":"Rivas","year":"2016","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb1085","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1172\/JCI107612","article-title":"Cell-mediated immune response of ragweed-sensitive patients to ragweed antigen E","volume":"53","author":"Rocklin","year":"1974","journal-title":"Journal of Clinical Investigation"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108115_bb1090","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0167-5699(91)90120-I","article-title":"Human TH1 and TH2 subsets: doubt no more","volume":"12","author":"Romagnani","year":"1991","journal-title":"Immunology Today"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108115_bb1095","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: Origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108115_bb1100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1084\/jem.121.1.185","article-title":"A new class of human immunoglobulins. II. Normal serum IgD","volume":"121","author":"Rowe","year":"1965","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2022.108115_bb1105","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"Journal of Immunology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb1110","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nri3464","article-title":"The plasticity and stability of regulatory T cells","volume":"13","author":"Sakaguchi","year":"2013","journal-title":"Nature Reviews Immunology"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108115_bb1115","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1586\/14760584.2015.1050385","article-title":"Current developments for improving efficacy of allergy vaccines","volume":"14","author":"Sandrini","year":"2015","journal-title":"Expert Review of Vaccines"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108115_bb1120","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/all.12198","article-title":"Causes of SLIT discontinuation and strategies to improve the adherence: a pragmatic approach","volume":"68","author":"Savi","year":"2013","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108115_bb1125","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2222.1986.tb01983.x","article-title":"Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite","volume":"16","author":"Scadding","year":"1986","journal-title":"Clinical Allergy"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108115_bb1130","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/cea.12953","article-title":"BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis","volume":"47","author":"Scadding","year":"2017","journal-title":"Clinical and Experimental Allergy"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb1135","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/jama.2016.21040","article-title":"Effect of 2 years of treatment with sublingual grass pollen immunotherapy on nasal response to allergen challenge at 3 years among patients with moderate to severe seasonal allergic rhinitis: The GRASS randomized clinical trial","volume":"317","author":"Scadding","year":"2017","journal-title":"JAMA."},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108115_bb1140","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-2222.2010.03462.x","article-title":"Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B","volume":"40","author":"Scadding","year":"2010","journal-title":"Clinical and Experimental Allergy"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb1145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.aller.2017.09.007","article-title":"Epicutaneous immunotherapy","volume":"45","author":"Scheurer","year":"2017","journal-title":"Allergologia et Immunopathologia"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108115_bb1150","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1080\/21645515.2017.1334745","article-title":"Allergen-specific immunotherapy of Hymenoptera venom allergy\u2013also a matter of diagnosis","volume":"13","author":"Schiener","year":"2017","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"10.1016\/j.pharmthera.2022.108115_bb1155","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejphar.2015.07.016","article-title":"Murine and human mast cell progenitors","volume":"778","author":"Schmetzer","year":"2016","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb1160","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.it.2018.11.001","article-title":"Professional and \u2018amateur\u2019 antigen-presenting cells in type 2 immunity","volume":"40","author":"Schuijs","year":"2019","journal-title":"Trends in Immunology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb1165","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jaci.2017.04.032","article-title":"Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells","volume":"141","author":"Schulten","year":"2018","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb1170","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/ACI.0b013e328332b8df","article-title":"Evidence of adherence to allergen-specific immunotherapy","volume":"9","author":"Senna","year":"2009","journal-title":"Current Opinion in Allergy and Clinical Immunology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb1175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000493647","article-title":"Intralymphatic immunotherapy: Update and unmet needs","volume":"178","author":"Senti","year":"2019","journal-title":"International Archives of Allergy and Immunology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108115_bb1180","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jaci.2009.07.019","article-title":"Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy","volume":"124","author":"Senti","year":"2009","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"46","key":"10.1016\/j.pharmthera.2022.108115_bb1185","doi-asserted-by":"crossref","first-page":"17908","DOI":"10.1073\/pnas.0803725105","article-title":"Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial","volume":"105","author":"Senti","year":"2008","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb1190","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jaci.2018.09.039","article-title":"Nasal allergen-neutralizing IgG 4 antibodies block IgE-mediated responses: Novel biomarker of subcutaneous grass pollen immunotherapy","volume":"143","author":"Shamji","year":"2019","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb1195","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1398-9995.2011.02745.x","article-title":"Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy","volume":"67","author":"Shamji","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.pharmthera.2022.108115_bb1200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2003.09.033","article-title":"Atopic dermatitis and the atopic march","author":"Spergel","year":"2003","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"6710","key":"10.1016\/j.pharmthera.2022.108115_bb1205","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/bmj.299.6710.1259","article-title":"Hay fever, hygiene, and household size","volume":"299","author":"Strachan","year":"1989","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108115_bb1210","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jaci.2007.11.021","article-title":"Indoleamine 2,3-dioxygenase-dependent tryptophan metabolites contribute to tolerance induction during allergen immunotherapy in a mouse model","volume":"121","author":"Taher","year":"2008","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108115_bb1215","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.180.8.5211","article-title":"1,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-\u03b2","volume":"180","author":"Taher","year":"2008","journal-title":"Journal of Immunology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb1220","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/ACI.0b013e3282f50e9d","article-title":"Long-term effects of asthma medications in children","volume":"8","author":"Tamesis","year":"2008","journal-title":"Current Opinion in Allergy and Clinical Immunology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb1225","first-page":"59","article-title":"Immunotherapy by inhalation of allergen in powder in house dust allergic asthma--a double-blind study","volume":"2","author":"Tari","year":"1992","journal-title":"Journal of Investigational Allergology & Clinical Immunology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb1230","first-page":"542","article-title":"Oral immunotherapy of adults with allergic rhinoconjunctivitis. Clinical effects in birch and grass pollinosis","volume":"39","author":"Taudorf","year":"1992","journal-title":"Danish Medical Bulletin"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb1235","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1398-9995.1983.tb04140.x","article-title":"Orally administered grass pollen","volume":"38","author":"Taudorf","year":"1983","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb1240","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2222.1971.tb02448.x","article-title":"Changes in nasal airways resistance on antigenic challenge in allergic rhinitis","volume":"1","author":"Taylor","year":"1971","journal-title":"Clinical & Experimental Allergy"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb1245","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2222.1972.tb01277.x","article-title":"Local nasal desensitization in allergic rhinitis","volume":"2","author":"Taylor","year":"1972","journal-title":"Clinical & Experimental Allergy"},{"issue":"1","key":"10.1016\/j.pharmthera.2022.108115_bb1250","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/1471-2458-12-204","article-title":"Global asthma prevalence in adults: Findings from the cross-sectional world health survey","volume":"12","author":"To","year":"2012","journal-title":"BMC Public Health"},{"issue":"6566","key":"10.1016\/j.pharmthera.2022.108115_bb1255","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/bmj.294.6566.250-b","article-title":"Desensitising vaccines","volume":"294","author":"Toogood","year":"1987","journal-title":"British Medical Journal"},{"issue":"9","key":"10.1016\/j.pharmthera.2022.108115_bb1260","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/17476348.2018.1507740","article-title":"Efficacy and effectiveness of omalizumab in the treatment of childhood asthma","volume":"12","author":"Tortajada-Girb\u00e9s","year":"2018","journal-title":"Expert Review of Respiratory Medicine"},{"key":"10.1016\/j.pharmthera.2022.108115_bb1265","article-title":"Evaluation of therapeutic sublingual vaccines in a murine model of chronic house dust mite allergic airway inflammation","volume":"1784\u20131792","author":"Tourdot","year":"2011","journal-title":"Clinical & Experimental Allergy"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb1270","first-page":"387","article-title":"Ligation of TLR9 induced on human IL-10-secreting Tregs by 1\u03b1,25-dihydroxyvitamin D3 abrogates regulatory function","volume":"119","author":"Urry","year":"2009","journal-title":"Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb1275","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jaci.2015.12.1299","article-title":"Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future","volume":"137","author":"Valenta","year":"2016","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2022.108115_bb1280","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-immunol-030409-101218","article-title":"From allergen genes to allergy vaccines","volume":"28","author":"Valenta","year":"2010","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.pharmthera.2022.108115_bb1285","first-page":"1251","article-title":"Asthme d\u2019origine \u00e9quine. Essai de d\u00e9sensibilisation par des cutir\u00e9actions r\u00e9p\u00e9t\u00e9es","volume":"45","author":"Vallery-Radot","year":"1921","journal-title":"Bull Soc M\u00e9d H\u00f4p Paris"},{"key":"10.1016\/j.pharmthera.2022.108115_bb1290","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/0021-8707(61)90103-4","article-title":"The effect of hyposensitization on the in vitro histamine release by specific antigen","volume":"32","author":"Van Arsdel","year":"1961","journal-title":"The Journal of Allergy"},{"key":"10.1016\/j.pharmthera.2022.108115_bb1295","series-title":"Global asthma network","article-title":"The global asthma report 2018","author":"Varghese","year":"2018"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb1300","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1172\/JCI116633","article-title":"Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses","volume":"92","author":"Varney","year":"1993","journal-title":"Journal of Clinical Investigation"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108115_bb1305","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/all.12465","article-title":"Vitamin D deficiency induces Th2 skewing and eosinophilia in neonatal allergic airways disease","volume":"69","author":"Vasiliou","year":"2014","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108115_bb1310","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jaci.2013.01.014","article-title":"IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses","volume":"131","author":"van de Veen","year":"2013","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"7","key":"10.1016\/j.pharmthera.2022.108115_bb1315","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s41591-019-0468-5","article-title":"A cellular census of human lungs identifies novel cell states in health and in asthma","volume":"25","author":"Vieira Braga","year":"2019","journal-title":"Nature Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb1320","first-page":"171","article-title":"The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy","volume":"14","author":"Vriala","year":"1999","journal-title":"Clinical and Experimental Allergy"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108115_bb1325","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0091-6749(03)02022-0","article-title":"Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy","volume":"112","author":"Wachholz","year":"2003","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb1330","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jaci.2011.08.034","article-title":"Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy","volume":"129","author":"Wambre","year":"2012","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb1335","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2013.10.054","article-title":"Specific immunotherapy modifies allergen-specific CD4+ T-cell responses in an epitope-dependent manner","volume":"133","author":"Wambre","year":"2014","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"22","key":"10.1016\/j.pharmthera.2022.108115_bb1340","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.2174\/1381612054546707","article-title":"Synthetic oligodeoxynucleotides containing deoxycytidyl-deoxyguanosine dinucleotides (CpG ODNs) and modified analogs as novel anticancer therapeutics","volume":"11","author":"Wang","year":"2005","journal-title":"Current Pharmaceutical Design"},{"issue":"8","key":"10.1016\/j.pharmthera.2022.108115_bb1345","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/90604","article-title":"The mucosal milieu creates tolerogenic dendritic cells and TR1 and TH3 regulatory cells","volume":"2","author":"Weiner","year":"2001","journal-title":"Nature Immunology"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb1350","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1172\/JCI13220","article-title":"Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy","volume":"108","author":"Wells","year":"2001","journal-title":"Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/j.pharmthera.2022.108115_bb1355","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1288\/00005537-197306000-00009","article-title":"A model for experimental vasomotor rhinitis","volume":"83","author":"Whicker","year":"1973","journal-title":"Laryngoscope"},{"issue":"11","key":"10.1016\/j.pharmthera.2022.108115_bb1360","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1046\/j.1365-2222.2001.01231.x","article-title":"Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium","volume":"31","author":"Wilson","year":"2001","journal-title":"Clinical and Experimental Allergy"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108115_bb1365","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jaci.2017.01.013","article-title":"Vitamin D supplementation in pregnancy, prenatal 25(OH)D levels, race, and subsequent asthma or recurrent wheeze in offspring: Secondary analyses from the Vitamin D Antenatal Asthma Reduction Trial","volume":"140","author":"Wolsk","year":"2017","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108115_bb1370","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/eji.201142018","article-title":"Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma","volume":"42","author":"Wolterink","year":"2012","journal-title":"European Journal of Immunology"},{"issue":"10","key":"10.1016\/j.pharmthera.2022.108115_bb1375","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.4049\/jimmunol.1001628","article-title":"IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis","volume":"185","author":"Yan","year":"2010","journal-title":"Journal of Immunology"},{"issue":"April","key":"10.1016\/j.pharmthera.2022.108115_bb1380","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.296.5567.490","article-title":"Allergy, parasites and the hygiene hypothesis","volume":"296","author":"Yazdanbakhsh","year":"2002","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.pharmthera.2022.108115_bb1385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1559325819870900","article-title":"Awareness and current therapeutics of asthma","volume":"17","author":"Zainab","year":"2019","journal-title":"Dose-Response"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108115_bb1390","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/ACI.0000000000000536","article-title":"Recombinant allergens for immunotherapy: State of the art","volume":"19","author":"Zhernov","year":"2019","journal-title":"Current Opinion in Allergy and Clinical Immunology"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108115_bb4001","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jaci.2012.02.014","article-title":"A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy","volume":"129","author":"Zimmer","year":"2012","journal-title":"J Allergy Clin Immunol."},{"issue":"2","key":"10.1016\/j.pharmthera.2022.108115_bb1395","doi-asserted-by":"crossref","first-page":"103","DOI":"10.18176\/jiaci.0349","article-title":"Adjuvants in allergen-specific immunotherapy: Modulating and enhancing the immune response","volume":"29","author":"Zubeldia","year":"2019","journal-title":"Journal of Investigational Allergology and Clinical Immunology"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725822000092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725822000092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:22:20Z","timestamp":1759011740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725822000092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":280,"alternative-id":["S0163725822000092"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108115","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allergen immunotherapy for allergic airway diseases: Use lessons from the past to design a brighter future","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108115"}}